South & Central America Aquaculture Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Vaccine (Live Vaccine, Inactivated Vaccine, and Others), Species (Tilapia, Trout, Salmon, Shrimps, and Others), and Route of Administration (Injection Vaccines, Immersion Vaccines, and Oral Vaccines)

No. of Pages: 118    |    Report Code: BMIRE00028134    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Aquaculture Vaccines Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Aquaculture Vaccines Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Aquaculture Vaccines Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing Aquaculture Industry Favors, the Market Growth
5.2 Market Opportunities
  • 5.2.1 Rising Prevalence of Infectious Diseases in Aquatic Animals Creates Significant Opportunities in the Market
5.3 Future Trends
  • 5.3.1 Development of Novel Vaccines
5.4 Impact of Drivers and Restraints

6. South & Central America Aquaculture Vaccines Market Regional Analysis

6.1 South & Central America Aquaculture Vaccines Market Overview
6.2 South & Central America Aquaculture Vaccines Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Aquaculture Vaccines Market Forecast Analysis

7. South & Central America Aquaculture Vaccines Market Analysis – by Type of Vaccine

7.1 Live Vaccine
  • 7.1.1 Overview
  • 7.1.2 Live Vaccine: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Inactivated Vaccine
  • 7.2.1 Overview
  • 7.2.2 Inactivated Vaccine: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Aquaculture Vaccines Market Analysis – by Species

8.1 Tilapia
  • 8.1.1 Overview
  • 8.1.2 Tilapia: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Trout
  • 8.2.1 Overview
  • 8.2.2 Trout: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Salmon
  • 8.3.1 Overview
  • 8.3.2 Salmon: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Shrimps
  • 8.4.1 Overview
  • 8.4.2 Shrimps: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Aquaculture Vaccines Market Analysis – by Route of Administration

9.1 Injection Vaccines
  • 9.1.1 Overview
  • 9.1.2 Shrimps: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Immersion Vaccines
  • 9.2.1 Overview
  • 9.2.2 Shrimps: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Oral Vaccines
  • 9.3.1 Overview
  • 9.3.2 Shrimps: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Aquaculture Vaccines Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Aquaculture Vaccines Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 South & Central America Aquaculture Vaccines Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Aquaculture Vaccines Market Breakdown, by Type of Vaccine
    • 10.1.1.1.2 Brazil: South & Central America Aquaculture Vaccines Market Breakdown, by Species
    • 10.1.1.1.3 Brazil: South & Central America Aquaculture Vaccines Market Breakdown, by Route of Administration
  • 10.1.1.2 Argentina: South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Aquaculture Vaccines Market Breakdown, by Type of Vaccine
    • 10.1.1.2.2 Argentina: South & Central America Aquaculture Vaccines Market Breakdown, by Species
    • 10.1.1.2.3 Argentina: South & Central America Aquaculture Vaccines Market Breakdown, by Route of Administration
  • 10.1.1.3 Rest of South and Central America : South & Central America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Aquaculture Vaccines Market Breakdown, by Type of Vaccine
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Aquaculture Vaccines Market Breakdown, by Species
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Aquaculture Vaccines Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Aquaculture Vaccines Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Elanco Animal Health Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 HIPRA SA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Merck & Co Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Phibro Animal Health Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Zoetis Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Tecnovax SA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 VETERQUIMICA SA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - S Market

  1. Elanco Animal Health Inc
  2. HIPRA SA
  3. Merck & Co Inc.
  4. Phibro Animal Health Corp
  5. Zoetis Inc.
  6. Tecnovax SA
  7. VETERQUIMICA SA